Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b, Single-Blind Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Three Separate Dose Levels of Very Low Dose-Glucagon Administered Subcutaneously Overnight for 6, 9 or 12 Hours in Subjects With Type 1 Diabetes Mellitus

NCT00304538 is registered in ClinicalTrials.gov with DiObex as lead sponsor.

NCT NCT00304538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00304538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b, Single-Blind Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Three Separate Dose Levels of Very Low Dose-Glucagon Administered Subcutaneously Overnight for 6, 9 or 12 Hours in Subjects With Type 1 Diabetes Mellitus
Lead sponsor
DiObex
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2006
Completion date
July 31, 2006
Enrollment
10
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes